Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer

British Journal of Surgery

Volumn 97, Issue 2, 2010, Pages 220-225

  Girelli, R ^a   Frigerio, I ^a   Salvia, R ^c   Barbi, E ^b   Tinazzi Martini, P ^b   Bassi, C ^c  

^a Hepatopancreatobiliary Unit   (Italy)

^b PEDERZOLI HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; ENDOSCOPIC ECHOGRAPHY; FEASIBILITY STUDY; HUMAN; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; PANCREAS TUMOR; PANCREATITIS; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEASIBILITY STUDIES; HUMANS; LENGTH OF STAY; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 74549191941     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6800     Document Type: Article

References (24)

1. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210.
2. Köninger J, Wente MN, Müller MW, Gutt CN, Friess H, Büchler MW. Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg 2007; 392: 13-21.
3. Vulfovich M, Rocha-Lima C. Novel advances in pancreatic cancer treatment. Expert Rev Anticancer Ther 2008; 8: 993-1002.
4. Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 2005; 9: 301-314.
5. Simon CJ, Dupuy DE. Current role of image-guided ablative therapies in lung cancer. Expert Rev Anticancer Ther 2005; 5: 657-666.
6. Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Graf H et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinoma: a pilot clinical study. Invest Radiol 2005; 40: 583-590.
7. Shariat SF, Raptidis G, Masatoschi M, Bergamaschi F, Slawin KM. Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer. Prostate 2005; 65: 260-267.
8. Noguchi M. Minimally invasive surgery for small breast cancer. J Surg Oncol 2003; 84: 94-101.
9. Martel J, Bueno A, Ortiz E. Percutaneous radiofrequency treatment of osteoid osteoma using cool tip electrode. Eur J Radiol 2005; 56: 403-408.
10. Gananadha S, Wulf S, Morris DL. Safety and efficacy of radiofrequency ablation of brain: a potentially minimally invasive treatment for brain tumors. Minim Invasive Neurosurg 2004; 47: 325-328.
11. Milićević M, Bulajić P, Zuvela M, Raznatović Z, Obradović V, Lekić N et al. [Elective resection of the spleen - overview of resection techniques and description for a new technique based on radiofrequency coagulation and dissection.] Acta Chir Iugosl 2002; 49: 19-24.
12. Siriwardena AK. Radiofrequency ablation for locally advanced cancer of the pancreas. JOP 2006; 7: 1-4.
13. Date RS, Siriwardena AK. Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 2005; 6: 588-592.
14. Matsui Y, Nakagawa A, Kamiyama Y, Yamamoto K, Kubo N, Nakase Y. Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 2000; 20: 14-20.
15. Spiliotis JD, Datsis AC, Michalopoulos NV, Kekelos SP, Vaxevanidou A, Rogdakis AG et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 2007; 392: 55-60.
16. Elias D, Baton O, Sideris L, Lasser P, Pocard M. Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumors. Eur J Surg Oncol 2004; 30: 85-87.
17. Varshney S, Sewkani A, Sharma S, Kapoor S, Naik S, Sharma A et al. Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP 2006; 7: 74-78.
18. Lygidakis NJ, Sharma SK, Papastratis P, Zivanovic V, Kefalourous H, Koshariya M et al. Microwave ablation in locally advanced pancreatic carcinoma - a new look. Hepatogastroenterology 2007; 54: 1305-1310.
19. Goldberg SN, Mallery S, Gazelle GS, Brugge WR. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 1999; 50: 392-401.
20. Date RS, McMahon RF, Siriwardena AK. Radiofrequency ablation of the pancreas. I: Definition of optimal thermal kinetic parameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP 2005; 6: 581-587.
21. Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB (Oxford) 2006; 8: 61-64.
22. Wu Y, Tang Z, Fang H, Gao S, Chen J, Wang Y et al. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol 2006; 194: 392-395.
23. Molinari E, Bassi C, Salvia R, Butturini G, Crippa S, Talamini G et al. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg 2007; 246: 281-287.
24. Bang UC, Semb S, Nojgaard C, Bendtsen F. Pharmacological approach to acute pancreatitis. World J Gastroenterol 2008; 14: 2968-2976.